These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39228052)

  • 1. Cancer Risks of Patients with Graves' Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis.
    Lee JY; Lee MK; Lee JH; Kim K; Bae K; Sohn SY
    Thyroid; 2024 Oct; 34(10):1271-1279. PubMed ID: 39228052
    [No Abstract]   [Full Text] [Related]  

  • 2. Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study.
    Cho YY; Kim B; Shin DW; Jang HR; Kim BY; Jung CH; Kim JH; Kim SW; Chung JH; Han K; Kim TH
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):281-289. PubMed ID: 35381687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
    Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in patients with Graves' disease: a nationwide cohort study.
    Chen YK; Lin CL; Chang YJ; Cheng FT; Peng CL; Sung FC; Cheng YH; Kao CH
    Thyroid; 2013 Jul; 23(7):879-84. PubMed ID: 23421548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
    Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
    Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Risk in Graves Disease with Radioactive
    Kim KJ; Choi J; Kim KJ; Song E; Yu JH; Kim NH; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG
    J Nucl Med; 2024 May; 65(5):693-699. PubMed ID: 38548348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves' hyperthyroidism: a multicentre study.
    Zuhur SS; Yildiz I; Altuntas Y; Bayraktaroglu T; Erol S; Sahin S; Kilinc F; Akbaba G; Topcu B; Elbuken G; Kadioglu P
    Endokrynol Pol; 2020; 71(3):207-212. PubMed ID: 32154572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
    Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
    JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Graves' disease in children: The Portuguese experience.
    Marques O; Antunes A; Oliveira MJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):143-149. PubMed ID: 29325833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Anti-Thyroid Medications in Patients with Graves' Disease.
    Mahzari MM; Alanazi MM; Alabdulkareem YM; Alharbi WA; Alzahrani AS; Alqahtani NA; Ajwah IM; Ardah HI
    BMC Endocr Disord; 2024 Sep; 24(1):180. PubMed ID: 39237901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
    Jin M; Jang A; Kim CA; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
    Eur Thyroid J; 2023 Apr; 12(2):. PubMed ID: 36826832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?
    Suzuki N; Noh JY; Yoshimura R; Mikura K; Kinoshita A; Suzuki A; Mitsumatsu T; Hoshiyama A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Sugino K; Ito K
    Thyroid; 2021 Sep; 31(9):1409-1415. PubMed ID: 33882721
    [No Abstract]   [Full Text] [Related]  

  • 20. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.